BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 4274290)

  • 1. The health insurance study: experimentation and health financing policy.
    Orr LL
    Inquiry; 1974 Mar; 11(1):28-39. PubMed ID: 4274290
    [No Abstract]   [Full Text] [Related]  

  • 2. Organization and administration for health affairs. Comment: state versus federal health policy.
    Thompson JD
    Inquiry; 1973 Mar; 10():Suppl 1:78-83. PubMed ID: 4267160
    [No Abstract]   [Full Text] [Related]  

  • 3. Health maintenance organizations: objectives and issues.
    Myers BA
    HSMHA Health Rep; 1971 Jul; 86(7):585-91. PubMed ID: 5147292
    [No Abstract]   [Full Text] [Related]  

  • 4. A design for a health insurance experiment.
    Newhouse JP
    Inquiry; 1974 Mar; 11(1):5-27. PubMed ID: 4274294
    [No Abstract]   [Full Text] [Related]  

  • 5. The cost and regulation of medical technology: future policy directions.
    Iglehart JK
    Milbank Mem Fund Q Health Soc; 1977; 55(1):25-59. PubMed ID: 559274
    [No Abstract]   [Full Text] [Related]  

  • 6. Policy options and the impact of national health insurance.
    Newhouse JP; Phelps CE; Schwartz WB
    N Engl J Med; 1974 Jun; 290(24):1345-59. PubMed ID: 4208037
    [No Abstract]   [Full Text] [Related]  

  • 7. National health insurance and family planning.
    Rosoff JI
    Fam Plann Perspect; 1971 Jul; 3(3):50-5. PubMed ID: 4941456
    [No Abstract]   [Full Text] [Related]  

  • 8. Financial management.
    Harvey JD
    Hospitals; 1972 Apr; 46(7):87-91. PubMed ID: 4552335
    [No Abstract]   [Full Text] [Related]  

  • 9. The health insurance study: a critical appraisal.
    Hester J; Leveson I
    Inquiry; 1974 Mar; 11(1):53-60. PubMed ID: 4274293
    [No Abstract]   [Full Text] [Related]  

  • 10. The implications of HMOs for private insurers.
    Eilers RD
    Inquiry; 1973 Mar; 10(1):59-63. PubMed ID: 4266930
    [No Abstract]   [Full Text] [Related]  

  • 11. The selling of HMOs: 1975.
    Lewis HL
    Mod Healthc (Short Term Care); 1975 May; 3(5):33-4, 36, 40. PubMed ID: 236500
    [No Abstract]   [Full Text] [Related]  

  • 12. HMOs: new horizons or organizational nightmares?
    Frederiksen G
    Hosp Prog; 1972 Apr; 53(4):42-8 passim. PubMed ID: 5025722
    [No Abstract]   [Full Text] [Related]  

  • 13. Four requisites for developing HMOs.
    Laur RJ
    Hosp Prog; 1972 Jan; 53(1):63-5 passim. PubMed ID: 5006938
    [No Abstract]   [Full Text] [Related]  

  • 14. Health policy uses and usefulness of cost-benefit and cost-effectiveness analysis.
    Warner KE
    Mead Johnson Symp Perinat Dev Med; 1982; (20):53-69. PubMed ID: 6821470
    [No Abstract]   [Full Text] [Related]  

  • 15. The health cost problem: is regulation our only hope?
    Helms RB
    Bull N Y Acad Med; 1980; 56(1):26-37. PubMed ID: 6766763
    [No Abstract]   [Full Text] [Related]  

  • 16. A perspective on federal health legislation. 1. Issues facing the 93rd Congress.
    Giolito C
    Hosp Community Psychiatry; 1973 Feb; 24(2):85-9. PubMed ID: 4705597
    [No Abstract]   [Full Text] [Related]  

  • 17. Editorial: Recharting national health priorities: a new Canadian perspective.
    Somers AR
    N Engl J Med; 1974 Aug; 291(8):415-6. PubMed ID: 4847356
    [No Abstract]   [Full Text] [Related]  

  • 18. Perspectives on government policy in the health sector.
    Blumstein JF; Zubkoff M
    Milbank Mem Fund Q Health Soc; 1973; 51(3):395-431. PubMed ID: 4762627
    [No Abstract]   [Full Text] [Related]  

  • 19. The American health insurance landscape.
    Geist RW; Harris D
    Minn Med; 2002 Jan; 85(1):12-6. PubMed ID: 12793225
    [No Abstract]   [Full Text] [Related]  

  • 20. Medicine and Public Affairs. Preparing for National Health Insurance, and other matters.
    Greenberg DS
    N Engl J Med; 1974 Nov; 291(22):1205-6. PubMed ID: 4472570
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.